Drugs / Manpixiao
last change Dec 2023 re-read 3 minutes ago

Manpixiao

Developed for
chronic atrophic gastritis
Investigated by
Beijing University of Chinese Medicine

Trials 1

20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 0 NCT05493124 Jul 2021 → Dec 2023 chronic atrophic gastritis Beijing University of Chinese Medicine Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Manpixiao ClinicalTrials.gov intervention name — accepted as the source's own label NCT05493124 ↗